Author

S. Banister

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 2 Assay:electrophysiology· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Organism:human· 1

Frequent Co-Authors

M. Connor· 4 shared C. Bladen· 2 shared M. Kassiou· 2 shared M. Longworth· 2 shared M. Santiago· 2 shared S. Sachdev· 2 shared A. Adams· 1 shared A. Makriyannis· 1 shared

Activity by Year

2018-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersPharmacology & Toxicology

M. Connor

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Modulation of Human T-type Calcium Channels by Synthetic Cannabinoid Receptor Agonists in vitro

C. Bladen, S. Mirlohi, M. Santiago, M. Longworth, M. Kassiou, S. Banister, M. Connor

This study investigates how synthetic cannabinoid receptor agonists modulate human T-type calcium channels, finding potent inhibition and suggesting a potential mechanism for their toxicity.

bioRxiv · Jul 22, 2020Pharmacology & Toxicology

Differential activation of G protein-mediated signalling by synthetic cannabinoid receptor agonists

S. Sachdev, S. Banister, M. Santiago, C. Bladen, M. ` Kassiou, M. Connor

This study compares how synthetic cannabinoid receptor agonists activate Gs and Gi/o proteins, finding differences in their potency and rank order for cAMP stimulation and inhibition.

bioRxiv · Nov 22, 2019 · PreprintPharmacology & Toxicology

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogues

S. Banister, R. Kevin, L. Martin, A. Adams, C. Macdonald, J. Manning, B. Rochelle, C. Michael, M. Stevens, I. McGregor, M. Glass, M. Connor, R. Gerona

This study synthesizes and characterizes new psychoactive substances (NPS) and evaluates their pharmacology at cannabinoid receptors.

bioRxiv · Oct 3, 2018Pharmacology & Toxicology

In vitro determination of the CB1 efficacy of illicit synthetic cannabinoids

S. Sachdev, K. Vemuri, S. Banister, M. Longworth, M. Kassiou, M. J. Santiago, A. Makriyannis, M. Connor

This study evaluates the efficacy of 13 synthetic cannabinoids at the CB1 receptor using receptor depletion and operational model fitting, finding most have higher efficacy than Δ9-THC.

bioRxiv · Aug 6, 2018Pharmacology & Toxicology